X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atrial fibrillation (11) 11
aged (7) 7
female (7) 7
humans (7) 7
index medicus (7) 7
male (7) 7
atrial fibrillation - drug therapy (6) 6
middle aged (6) 6
abridged index medicus (4) 4
cardiac & cardiovascular systems (4) 4
double-blind method (4) 4
drug therapy (4) 4
aged, 80 and over (3) 3
atrial flutter - drug therapy (3) 3
cardiac arrhythmia (3) 3
cardiovascular (3) 3
classical music (3) 3
diseases of the circulatory system (3) 3
embolism (3) 3
follow-up studies (3) 3
hemorrhage (3) 3
hemorrhage - chemically induced (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
medicine, general & internal (3) 3
pharmacological cardioversion (3) 3
stroke (3) 3
stroke - prevention & control (3) 3
treatment outcome (3) 3
warfarin (3) 3
anti-arrhythmia agents - adverse effects (2) 2
anti-arrhythmia agents - therapeutic use (2) 2
anticoagulation (2) 2
arrhythmia (2) 2
arrhythmias (2) 2
aspirin (2) 2
atrial fibrillation - complications (2) 2
atrial flutter (2) 2
care and treatment (2) 2
dabigatran (2) 2
direct current cardioversion (2) 2
dose-response relationship, drug (2) 2
effectiveness (2) 2
electrocardiography, ambulatory (2) 2
embolism - prevention & control (2) 2
events (2) 2
factor xa (2) 2
factor xa inhibitors (2) 2
fibrillation (2) 2
health aspects (2) 2
heart (2) 2
hospitalization (2) 2
hospitalization - statistics & numerical data (2) 2
medical research (2) 2
pyrazoles (2) 2
pyrazoles - adverse effects (2) 2
pyrazoles - therapeutic use (2) 2
pyridones (2) 2
pyridones - adverse effects (2) 2
pyridones - therapeutic use (2) 2
refralon (2) 2
risk factors (2) 2
safety (2) 2
stroke - epidemiology (2) 2
therapeutics. pharmacology (2) 2
trial (2) 2
acute coronary syndromes (1) 1
administration, oral (1) 1
adrenoceptor (1) 1
adult (1) 1
aging (1) 1
amiodarone (1) 1
amiodarone - adverse effects (1) 1
amiodarone - analogs & derivatives (1) 1
amiodarone - therapeutic use (1) 1
amiodarone-like agent (1) 1
aneurysm (1) 1
antagonists (1) 1
anti-arrhythmia agents - administration & dosage (1) 1
anti-arrhythmia agents - blood (1) 1
antiarrhythmic treatment (1) 1
antiarrhythmic-drugs (1) 1
anticoagulants (1) 1
anticoagulants - adverse effects (1) 1
anticoagulants - therapeutic use (1) 1
antithrombins - administration & dosage (1) 1
antithrombins - adverse effects (1) 1
antithrombotic therapy (1) 1
arterial hypertension (1) 1
article subject (1) 1
aspirin - adverse effects (1) 1
aspirin - therapeutic use (1) 1
atrial appendage - metabolism (1) 1
atrial appendage - pathology (1) 1
atrial fibrillation - blood (1) 1
atrial fibrillation - metabolism (1) 1
atrial fibrillation - mortality (1) 1
atrial fibrillation - pathology (1) 1
atrial fibrillation - physiopathology (1) 1
atrial fibrillation and flutter (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 9, pp. 806 - 817
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 11, pp. 981 - 992
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 24, pp. 2268 - 2276
Patients with permanent atrial fibrillation and additional cardiac risk factors were randomly assigned to receive either dronedarone or placebo. At a median of... 
HEART | ARRHYTHMIAS | MORTALITY | ADRENOCEPTOR | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SR-33589 | AMIODARONE-LIKE AGENT | Follow-Up Studies | Humans | Anti-Arrhythmia Agents - blood | Hospitalization - statistics & numerical data | Male | Amiodarone - adverse effects | Heart Rate - drug effects | Stroke - chemically induced | Amiodarone - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Drug Therapy, Combination | Digoxin - blood | Digoxin - therapeutic use | Heart Failure - epidemiology | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - therapeutic use | Amiodarone - analogs & derivatives | Atrial Fibrillation - blood | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Chronic Disease | Heart Failure - chemically induced | Drugs | Product/Service Evaluations | Drug therapy | Atrial fibrillation | Heart failure | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Medical research | Arrhythmia | Cardiovascular disease | Hospitalization | Embolism | Risk factors | Heart rate | Sinuses | Fibrillation | Death | Blood pressure | Ventricle | Acute coronary syndromes | Heart diseases | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Circulation, ISSN 0009-7322, 07/2013, Volume 128, Issue 3, pp. 237 - 243
Journal Article
Cor et Vasa, ISSN 0010-8650, 2016, Volume 59, Issue 5, pp. e450 - e453
Abstract Rate control is an acceptable strategy in management of patients with recurrent atrial fibrillation. Typically, it is more simple approach than rhythm... 
Cardiovascular | Atrial fibrillation and flutter | Spontaneous conversion | Orthostatic hypotension | Rate control
Journal Article
Case Reports in Cardiology, ISSN 2090-6404, 12/2015, Volume 2015, pp. 1 - 6
Cardiac involvement is a well-known feature of neuromuscular diseases. Most commonly cardiac manifestations occur later in the course of the disease.... 
Case Report
Journal Article
Rational Pharmacotherapy in Cardiology, ISSN 1819-6446, 2018, Volume 14, Issue 5, pp. 664 - 669
Aim. We aimed to compare effectiveness of new  class III antiarrhythmic drug  Refralon with direct current  cardioversion (DCC) in patients with persistent... 
Refralon | Direct current cardioversion | Effectiveness | Safety | Atrial fibrillation | Pharmacological cardioversion | pharmacological cardioversion | effectiveness | atrial fibrillation | direct current cardioversion | refralon | safety
Journal Article
Journal Article
Rational Pharmacotherapy in Cardiology, ISSN 1819-6446, 2018, Volume 14, Issue 6, pp. 826 - 830
Aim. To compare safety of new class III antiarrhythmic drug Refralon with direct current cardioversion (DCC) in patients with persistent atrial fibrillation... 
Refralon | Direct current cardioversion | Effectivenes | Safety | Atrial fibrillation | Pharmacological cardioversion | pharmacological cardioversion | effectiveness | atrial fibrillation | direct current cardioversion | refralon | safety
Journal Article
Cor et Vasa, ISSN 0010-8650, 2015, Volume 57, Issue 5, pp. e347 - e353
Abstract This case presents an episode of electrical storm (ES) in post-myocardial infarction patient results from myocarditis. ES was interrupted by... 
Cardiovascular | Myocarditis | Radiofrequency catheter ablation | Electrical storm | Autoantibodies to beta1-adrenergic receptor | Ventricular tachicardia | Aneurysm
Journal Article